Paasa Logo
Surgical Innovations Group plc logo
SUNLSEMarket openCloses 4:30pm UK

Surgical Innovations Group plc

£0.00Last updated
-£0.00 (8.72%)Past day
Timezone

Surgical Innovations Group plc (LSE: SUN) is trading at £0.00, about ₹0 at today's GBP/INR rate, as of 30 Sep 2026, 9:16 AM ET, down 8.72% today. Indian residents can buy Surgical Innovations from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:£0.00
Previous close:£0.00
Volume:2.35M

Today's low

£0.00

Today's high

£0.00

52 week low

£0.00

52 week high

£0.01

SUN opened at £0.00, closed previously at £0.00, and has traded between £0.00 and £0.01 over the past 52 weeks.

About

Established in 1988 and headquartered in Leeds, United Kingdom, Surgical Innovations Group plc is an international enterprise engaged in the design, development, manufacturing, and marketing of devices for minimally invasive surgery (SI) and precision engineering applications. Its global presence extends across the UK, Europe, the Asia Pacific region, and the United States. The company operates through three distinct divisions: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The SI Brand segment is responsible for the research, development, production, and commercialization of its proprietary SI-branded minimally invasive instruments. Key products within this portfolio include the YelloPort Elite and YelloPort +plus laparoscopic port access systems, LogiRange resposable laparoscopic instrument systems, FastClamp laparoscopic clamping systems, and QuickRange single-use laparoscopic instrumentation. The OEM division focuses on crafting and supplying minimally invasive devices for third-party medical device firms, often under their own brand or through co-branding arrangements. This segment also provides comprehensive design and development solutions for creating final medical devices and is involved in the research, development, manufacturing, and sale of minimally invasive technology tailored for precision engineering. Lastly, the Distribution segment handles the supply of various medical products, primarily via its subsidiary, Elemental Healthcare Ltd, and also designs and produces autologous blood products. Surgical Innovations Group plc sells its offerings through a network of independent healthcare distributors, while its own-label products are also distributed through its OEM collaborations.

Country
GB
CEO
David John Marsh
Exchange listed on
LSE
Industry
Medical - Devices
Base currency
GBP
Full Time Employees
82
Sector
Healthcare
IPO date
08/12/1988

Key statistics

Avg. volume

387.46K

Market cap

£3.41M

P/E Ratio

-3.65

Price-to-sales ratio

0.29

Enterprise value

£4.05M

Free cash flow yield

12.10%

Debt-to-equity ratio

0.09

Return on equity

-11.71%

ROIC

-8.08%

Beta

0.09

Dividend yield

0.00%

Last dividend

£0.00

Financial overview

Revenue

£11.60M

Earnings per share

-£0.00

Free cash flow

£508.00K

Net profit margin

-7.71%

Gross margin

26.31%

EBITDA

-£73.00K

Revenue growth

-2.87%

Similar securities

This is not an investment recommendation

How to buy Surgical Innovations from India

Indian residents can buy Surgical Innovations shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.

  3. Search for Surgical Innovations and place an order

    Find Surgical Innovations by name or by its ticker, SUN, and choose an order type. Surgical Innovations trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Surgical Innovations position in GBP and INR. Surgical Innovations pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Surgical Innovations from India

Trading and taxes when buying Surgical Innovations from India

Trading and limits

Trading hours
8:00 am – 4:30 pm UK
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneSurgical Innovations does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Transaction tax
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
Estate or inheritance tax
May applyShares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.Estate tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Surgical Innovations stock?

Yes. Surgical Innovations (SUN) has been listed on the London Stock Exchange since 1988, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Surgical Innovations share cost in rupees?

One Surgical Innovations share is £0.00 — about ₹0 at a GBP/INR rate of 127.06 on 29 Sep 2026. Both the Surgical Innovations price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Surgical Innovations from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Surgical Innovations shares taxed in India?

Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the Surgical Innovations price. Paasa issues a capital-gains statement for your return.

Does Surgical Innovations pay a dividend?

No. Surgical Innovations does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Surgical Innovations from India?

The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Surgical Innovations shares held from India?

Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. It applies to your overall holdings in that jurisdiction rather than to any one position.

Are there transaction taxes when buying Surgical Innovations?

The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.

Do I have to declare Surgical Innovations shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Surgical Innovations holding, its cost and its closing value.

How do I sell Surgical Innovations and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.